Concepedia

Peter H. Dobbelaar

PH

Statistics

Publications

13

Citations

318

H-Index

12

Active since

2009

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Albany Molecular Research (United States)

Seton Hall University

United States Military Academy

Peter H. Dobbelaar is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

2009–2015

13

Publications

13

Regulation of Energy Homeostasis by Bombesin Receptor Subtype-3: Selective Receptor Agonists for the Treatment of Obesity

Xiao-Ming Guan, Howard Chen, Peter H. Dobbelaar et al. · Cell Metabolism · 2010 · 87 citations · Full text

, , +16

Synthesis and SAR of derivatives based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity

Jian Liu, Shuwen He, Tianying Jian et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 29 citations · Full text

, , +9

Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonists

Shuwen He, Peter H. Dobbelaar, Jian Liu et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 25 citations · Full text

, , +9

Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 Diabetes

Shrenik K. Shah, Shuwen He, Liangqin Guo et al. · ACS Medicinal Chemistry Letters · 2015 · 23 citations · Full text

, , +14

Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonist

Shuwen He, Zhixiong Ye, Peter H. Dobbelaar et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 23 citations · Full text

, , +9

1–5 of 13